Rituximab for relapsing-remitting multiple sclerosis

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The effectiveness and safety of rituximab alone or as add-on, versus placebo or other treatments for relapsing-remitting multiple sclerosis will be assessed.